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Abstract
The basic helix-loop-helix (bHLH) transcription factor ASCL2 plays essential roles in diploid
multipotent trophoblast progenitors, intestinal stem cells, follicular T-helper cells, as well as
during epidermal development and myogenesis. During early development, Ascl2 expres-
sion is regulated by genomic imprinting and only the maternally inherited allele is transcrip-
tionally active in trophoblast. The paternal allele-specific silencing of Ascl2 requires
expression of the long non-coding RNA Kcnq1ot1 in cis and the deposition of repressive his-
tone marks. Here we show that Del7AI, a 280-kb deletion allele neighboring Ascl2, interferes
with this process in cis and leads to a partial loss of silencing at Ascl2. Genetic rescue exper-
iments show that the low level of Ascl2 expression from the paternal Del7AI allele can rescue
the embryonic lethality associated with maternally inherited Ascl2 mutations, in a level-
dependent manner. Despite their ability to support development to term, the rescued pla-
centae have a pronounced phenotype characterized by severe hypoplasia of the junctional
zone, expansion of the parietal trophoblast giant cell layer, and complete absence of inva-
sive glycogen trophoblast cells. Transcriptome analysis of ectoplacental cones at E7.5 and
differentiation assays of Ascl2 mutant trophoblast stem cells show that ASCL2 is required
for the emergence or early maintenance of glycogen trophoblast cells during development.
Our work identifies a new cis-acting mutation interfering with Kcnq1ot1 silencing function
and establishes a novel critical developmental role for the transcription factor ASCL2.
Author summary
By controlling precise networks of target genes, transcription factors play important roles
in cell fate determination during development. The Ascl2 gene codes for a transcription
factor essential for the maintenance of progenitor cell populations able to differentiate
into specialized cell types in the intestine and in the extra-embryonic trophoblast lineage.
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The trophoblast is an essential component of the placenta, an organ required for develop-
ment of the embryo in placental mammals. Ascl2 belongs to a group of unusual genes,
called imprinted genes, which are expressed from only a single parental copy. Ascl2 is only
expressed from the maternally inherited copy in the trophoblast, the paternal copy being
kept silent. Here, we describe an engineered deletion neighboring Ascl2 that interferes
with the complete silencing of the paternal copy of the gene. We show that the low amount
of ASCL2 produced from this deletion can rescue the embryonic lethality associated with
non-functional maternal copies of Ascl2. Although the rescued embryos can often survive
to term, their placenta is highly disorganized and lacks members of a specific cell lineage,
the trophoblast glycogen cells. By analyzing the transcriptional profile of mutant tropho-
blast progenitors in vivo and of differentiated trophoblast stem cells, we show that ASCL2
plays a very early role in the formation of this cell lineage.
Introduction
The Ascl2 gene—previously known as Mash2—was originally cloned as a mammalian homo-
logue of Drosophila achaete-scute genes and codes for a group A bHLH transcription factor
[1,2]. In mice, Ascl2 is required for development. Homozygous Ascl2 knock-out mice die at
~E10 due to an extra-embryonic phenotype which can be rescued by providing a functional
tetraploid trophoblast lineage [3]. More recently, Ascl2 was shown to play critical roles in a
number of other cell types and developmental processes, including intestinal stem cells [4],
epidermal development [5], myogenesis [6], and follicular T-helper cells [7]. ASCL2 acts by
hetero-dimerization with ubiquitous bHLH factors of the E protein family, such as TCF3/
E12-E47, TCF4/E2-2/ITF2, and TCF12/HEB/ALF1 [4,6,8]. These studies have shown that
ASCL2-E-protein complexes promote transcriptional activation, although during myogenesis
ASCL2 inhibits the action of bHLH myogenic factors by sequestration of E proteins [6], sug-
gesting context-dependent mechanisms for ASCL2 function.
Ascl2 is an imprinted gene in the mouse, expressed only from the maternal allele in tropho-
blast cells [9]. Consequently, embryos inheriting a maternal null allele (denoted Ascl2KO/+) fail
to develop past mid-gestation, whereas paternal heterozygotes (Ascl2+/KO) are fully viable.
Imprinting at Ascl2 is tissue-specific: it is biallelically expressed in LGR5-positive intestinal
stem cells [4], although the mechanism involved in this tissue-specific loss of imprinting (LOI)
is still unknown. In trophoblast, the paternal allele of Ascl2 is silenced by the paternally
expressed long non-coding RNA (lncRNA) Kcnq1ot1, which bidirectionally establishes a
repressive epigenetic domain in cis, covering more than 600 kb on distal Chr7 [10–15]. As a
consequence, Ascl2 is only expressed from the maternal allele, as are seven other protein-cod-
ing genes in the region [16].
Ascl2 transcripts are deposited in the oocyte and zygotic transcription starts at the late two-
cell stage [17]. Despite this early expression, Ascl2 is first required only postimplantation, since
maternal and zygotic mutants are both embryonic lethal at ~E10 [3,17]. Following implanta-
tion, the polar trophectoderm (TE) proliferates under FGF signaling from the underlaying epi-
blast [18]. These few cells will form a population of extra-embryonic ectoderm cells from
which all the trophoblast cell types of the placenta will differentiate, with the exception of pri-
mary parietal trophoblast giant cells (P-TGCs), which are derived from the mural trophecto-
derm [19]. As it expands in the proximal-distal axis, this mass of diploid trophoblast cells
forms two morphologically distinct structures: (i) the ectoplacental cone (EPC), surrounded
by secondary P-TGCs, derived from precursors in the EPC by endoreduplication, that are in
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direct contact with the decidua basalis; and (ii) the extra-embryonic ectoderm (ExE), extend-
ing from the EPC down to the epiblast. From E6.5 to E7.5, high levels of Ascl2 are mostly
restricted to diploid cells of the EPC, as FGF4 and Nodal signaling from the epiblast prevents
high levels of expression in the stem cell compartment of the ExE and its derivative, the chori-
onic ectoderm (ChE) [20–22]. With the occlusion of the ectoplacental cavity and the con-
comitant loss of stem cell potential in ChE between E8.0 and 8.5 [23], Ascl2 remains highly
expressed in the EPC but is also detected throughout most of the ChE [8,17]. Subsequently,
from E9.0 to E12.5, Ascl2 is detected in specific derivatives of the EPC and the ChE, namely
spongiotrophoblast (SpT) cells of the junctional zone (Jz) and some labyrinth trophoblast of
unknown cell type, respectively [8,17,24].
The phenotype of Ascl2-deficient conceptuses is characterized by an inability to maintain
diploid precursors within the EPC and a consequent absence of Tpbpa-positive Jz cells at E9.5
[3]. In the absence of Ascl2, multipotent EPC cells appear to default to the P-TGC lineage,
resulting in an expansion of the P-TGC layer. Consistent with a transient role in specific multi-
potent diploid EPC and SpT cells, Ascl2 levels decline past E12.5 and no expression is detected
in differentiated derivatives of those cells, such as glycogen trophoblast (GlyT) cells and three
giant cell lineages: P-TGCs, canal TGCs (C-TGCs), and spiral artery-associated TGCs
(SpA-TGCs) [25–27].
We previously described the generation of a ~280-kb deletion spanning the Ascl2-Ins2
intergenic region and encompassing the gene for tyrosine hydroxylase, Th (Fig 1A) [28].
This deletion—called Del7AI—does not interfere with the establishment or maintenance of
differential DNA methylation at the two neighbouring imprinting centers (ICs) regulating,
amongst other genes, the lncRNAs H19 and Kcnq1ot1. However, maternal transmission of
Del7AI, recovered at the expected Mendelian ratio, leads to an intrauterine growth restriction
phenotype [24]. Del7AI/+ placentae express Ascl2 at ~60% of wild-type levels, are highly dis-
organized, but can still support development to term. As in the full Ascl2 KO, these Ascl2
hypomorphs show an expanded P-TGC layer but here a very thin Jz is maintained through-
out gestation. Consequently, the labyrinth layer in these mutant placentae show an impor-
tant proximal expansion of the fetal vasculature, suggesting a role for the Jz in restricting
growth of the placental vessels [24]. In the mature placenta, the Jz is normally composed of
two distinct diploid cell types, SpT and GlyT cells, both derived from the EPC [27]. Although
Del7AI/+ placentae maintained a small layer of SpT cells, we could not detect GlyT cells in
these mutants, suggesting a role for ASCL2 in the differentiation and/or maintenance of this
trophoblast lineage [24]. The GlyT cell type was previously thought to be established past
mid-gestation due to the emergence of vacuolated cells within the Jz at ~E12 that also express
junctional zone-specific genes such as Tpbpa [29–31]. However, specific markers of these
mature GlyT cells, notably Pcdh12 and Aldh1a3, have since been shown to be expressed in a
subset of EPC cells at E7.5 and E8.5, respectively, suggesting an earlier origin for this lineage
[32,33].
Here we report that paternal inheritance of Del7AI interferes with silencing at Ascl2 in cis,
causing partial LOI and providing enough Ascl2 mRNA to rescue maternally inherited Ascl2
mutations. The rescued conceptuses share several phenotypic characteristics with our previ-
ously described Del7AI/+ hypomorphs, but show an even more pronounced placental pheno-
type, associated with lower rates of postnatal survival. Our analysis of these mutant placentae,
together with RNA-seq profiling of E7.5 EPCs and differentiation assays of Ascl2-deficient tro-
phoblast stem cells (TSCs), show that ASCL2 plays an essential role in the early specification
or maintenance of GlyT cell precursors in the EPC during development, establishing a novel
important function for this transcription factor in the trophoblast lineage.
ASCL2 and glycogen trophoblast cells
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Results
Partial loss of imprinting at Ascl2 in paternal +/Del7AI heterozygotes
Paternal transmission of Del7AI is not associated with any obvious developmental or postnatal
phenotypes [28]. However, expression studies suggested that total Ascl2 levels might be
increased in +/Del7AI placentae at E9.5 compared to their wild-type littermates [24]. We first
asked whether Del7AI interferes with the epigenetic silencing of Ascl2 and other Kcnq1ot1-regu-
lated genes when paternally inherited (Fig 1A). For these allele-specific studies, we crossed
+/Del7AI males with females homozygous for a Mus mus. castaneus (C) distal Chr7 haplotype
Fig 1. Loss of imprinting at Ascl2 in +/Del7AI placentae. (A) Simplified map of the imprinted region on distal mouse Chr7.
Maternally expressed genes are shown in red, paternally expressed genes in blue. The gametic differentially methylated regions
acting as imprinting centres (IC) in the H19 and Kcnq1ot1 sub-domains are labelled as IC1 and IC2, respectively. Location of the
Del7AI deletion is shown on the left, transcriptional orientation of each gene (arrows), on the right. (B) Allele-specific expression
analysis for Ascl2, Tssc4, Cdkn1c, and Phlda2, on E13.5 placental cDNA. M and P show the position of the maternal and paternal
bands, respectively. The 2M+P band contains two maternal bands and 1 paternal band; M+P, co-migrating maternal and paternal
bands. Informative SNPs are boxed. For the Cdkn1c SNP, CAST = C and 129 = T; and for Phlda2, CAST = C and the 129 = A. C:
WT CAST allele; +: WT 129 allele. (C) Maternal to paternal allele expression ratio (M to P ratio) for wild-type (C/+) and paternal
deletion mutants (C/Del7AI). (D) Total expression levels in E15.5 placentae determined by RT-qPCR for three biological replicates
per genotype. Error bars: SD for biological replicates. Expression is relative to Ppia levels. p<0.005.
https://doi.org/10.1371/journal.pgen.1007587.g001
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on the C57BL/6J background to obtain C/Del7AI and C/+ embryos. We analyzed the ratios of
expressed SNPs at four Kcnq1ot1 targets—Ascl2, Tssc4, Cdkn1c, and Phlda2—from E13.5 pla-
cental RNA. Our results provide direct evidence of abnormal paternal Ascl2 expression in C/
Del7AI placentae, indicating that Ascl2 is not properly silenced from the paternal Del7AI allele
and exhibits partial loss of imprinting (LOI) (Fig 1B). We also noticed slight paternal expres-
sion for the neighboring gene Tssc4, although in wild-type conceptuses this gene is not tightly
imprinted, as also shown by others [34]. In contrast, the more distal imprinted genes Cdkn1c
and Phlda2 showed no indication of LOI in the mutant placentae (Fig 1B). Maternal to pater-
nal expression ratios confirmed that partial LOI was occurring at Ascl2 and Tssc4, but not at
Cdkn1c or Phlda2 in paternal heterozygous Del7AI placentae (Fig 1C). We also assessed total
levels of gene expression by RT-qPCR and found corresponding significant increases in total
Ascl2 (1.4-fold) and Tssc4 (1.6-fold) mRNA levels in E15.5 +/Del7AI placentae compared to
wild types, but not for the two other genes analyzed (Fig 1D). LOI at Ascl2 was also quantified
by blotting of restriction fragment length polymorphism analysis and confirmed using a
strain-specific primer (S1 Fig). Together, our results show that the paternal allele of Ascl2 is
expressed at ~30% of the maternal allele levels in +/Del7AI heterozygotes, representing ~23% of
the total Ascl2 levels in the mutants.
We previously showed that Kcnq1ot1 is expressed and normally imprinted in +/Del7AI
embryos [28]. However, our analysis only documented transcription close (1.3 kb) to its tran-
scription start site (TSS). The main stable and polyadenylated isoform of Kcnq1ot1 spans ~83
kb and covers parts of introns 11 and 10 of Kcnq1 [35]. However, transcripts extending all the
way to ~121 kb and ~470 kb downstream of the TSS and requiring a functional Kcnq1ot1 pro-
moter have also been reported, although their abundance relative to the shorter isoform is con-
flicting [35,36]. Nevertheless, since the polyadenylated 470-kb isoform extends 130 kb within
the region deleted in Del7AI (S2A Fig), this raised the possibility that its production from the
deletion allele might be perturbed in +/Del7AI mutants showing partial LOI at Ascl2. Using
primer pairs amplifying regions at 0.3, 202, and 307 kb from the Kcnq1ot1 TSS, we were able
to replicate the published data [36] and confirm transcription up to 21.3 kb upstream of Ascl2
(307k PCR reaction) in wild-type E13.5 placenta (S2B Fig). Expression of the longer Kcnq1ot1
isoform was also detected in +/Del7AI placentae, arguing against a major interference with the
production of the lncRNA up to the deletion breakpoint (S2B Fig).
Importantly, Igf2mRNA levels and expression pattern are not perturbed in the mutants,
arguing against a spreading of Kcnq1ot1 silencing effects to the paternally expressed Igf2 gene
in cis, across the deletion breakpoints (Fig 1A and S3 Fig). This result is consistent with the
observation that +/Del7AI mice do not exhibit an abnormal growth phenotype [28].
Elevated Ascl2 levels in differentiated +/Del7AI trophoblast stem cells
To develop a cell culture-based system for further analyses of this deletion, we established tro-
phoblast stem cell (TSC) lines from blastocysts carrying a maternally or paternally inherited
Del7AI allele. Ascl2 levels peak between days 1 and 3 of TSC differentiation induced by FGF4
withdrawal [18,21,37–40]. Furthermore, RNA-seq profiling of hybrid TSC lines showed that
Ascl2 is already imprinted in undifferentiated TSCs, with more than 90% of expression coming
from the maternal allele [41]. We used RT-qPCR to quantitate Ascl2 mRNA levels in wild-
type and Del7AI heterozygous TSCs after 2 days of differentiation by culture in the absence of
FGF4 and conditioned medium (S4A Fig). The paternal Del7AI allele causes a significant
increase in total Ascl2 levels in these differentiated mutant cell lines compared to wild-type
cells (~1.6-fold), in support of our observations in vivo (Fig 1D), and consistent with LOI at
Ascl2 in +/Del7AI mutant TSCs.
ASCL2 and glycogen trophoblast cells
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Rescue of Ascl2 deficiency by paternal inheritance of the Del7AI allele
Maternal transmission of the Ascl2 knock-in allele Ascl2lacZ (official name Ascl2tm1.1Nagy)
results in embryonic lethality at ~E10.0, as seen for the null allele [3], even though the bicistro-
nic Ascl2-IRES-lacZmRNA of this allele should produce a functional ASCL2 protein [42]. We
found that the Ascl2 mRNA from this allele is produced at only ~11% of wild-type levels in
mutant Ascl2lacZ/+ ectoplacental cones at E7.5 (see below). We crossed Ascl2+/lacZ females with
+/Del7AI males to determine if the small amount of paternal Ascl2 expression from Del7AI
could rescue the embryonic lethality seen in Ascl2lacZ/+ mutants. We focused on in utero stages
beyond the E10 lethality (E12.5–18.5) as well as on live pups the day following delivery (P0, Fig
2). Since Ascl2lacZ is considered a weak, hypomorphic mutation [42], we also performed similar
crosses with the original Ascl2 null allele (Ascl2KO, official name Ascl2tm1Alj) to assess the effects
of total Ascl2 levels on our results [3]. First, we observed that both mutant Ascl2 alleles give
very few Ascl2-/+ live revertants when crossed to wild-type males, a phenotypic rescue that
would require activation of the normally silent paternal allele of Ascl2. No live Ascl2KO/+
embryos or pups were obtained from 20 litters (0/91.5, observed/expected). For the Ascl2lacZ
allele, 4 Ascl2lacZ/+ embryos were recovered beyond E12.5 from 13 litters from wild-type males,
but 3 of these were small and necrotic, suggesting incomplete resorption. Furthermore, two
live Ascl2lacZ/+ pups were recovered from 43 litters implicating wild-type and +/Del7AI males,
leading to an overall epigenetic reversion rate of ~0.9% (3/333) for Ascl2lacZ/+ progeny (Fig 2).
Our results show that the paternal Del7AI allele acts as a strong suppressor of the Ascl2lacZ
phenotype, with more than 75% of the expected Ascl2lacZ/Del7AI compound heterozygotes sur-
viving past E15 (Fig 2A and S1.1 Table). This phenotypic rescue is sensitive to the overall levels
of Ascl2 mRNA since we observed a marked decrease in the developmental rescue of the null
allele Ascl2KO by Del7AI, which plummets to ~7%. We also found that for live pups, just over
22% of the expected Ascl2lacZ/Del7AI mice survived to term, down from ~75% rescue in utero,
suggesting that although they can develop through late gestation, several of these conceptuses
do not survive perinatally. Consistent with this possibility, Ascl2lacZ/Del7AI rescued embryos
appeared normal, although growth retarded (see below), as late as E17.5 in gestation (S1.1
Table). Nevertheless, the observed frequencies of phenotypic rescue of the Ascl2lacZ allele, but
not of Ascl2KO, by Del7AI are highly significant, both in utero and at birth (Fig 2, and S1 Table).
Live rescued Ascl2lacZ/Del7AI pups are growth-retarded and this growth phenotype largely
persists until weaning age (Fig 3A). Since this growth retardation was already observed at
birth, we measured the placental and embryonic weights of rescued Ascl2lacZ/Del7AI concep-
tuses at E15.5. We noticed a significant (~29%) reduction in placental weight compared to
their wild-type littermates (Fig 3B). Embryonic weights of the mutants were also smaller than
wild-type littermates at this stage (~21%) (Fig 3C). We have previously reported that there is
no difference in placental and embryonic weights in +/Del7AI hemizygotes compared to wild-
type littermates [24]. These rescue experiments provide genetic evidence that Del7AI causes
LOI at Ascl2 and reveal a novel hypomorphic Ascl2 phenotype in rescued, growth retarded
conceptuses.
Ascl2lacZ/Del7AI placentae exhibit an expanded giant cell layer, a hypoplastic
spongiotrophoblast, and lack glycogen trophoblast cells
The results presented above suggest that Ascl2 levels are suboptimal and lead to a placental
phenotype in rescued conceptuses. This possibility was first studied by histological analyses of
placental sections at E15.5 (Fig 4). As described for the growth-retarded Del7AI/+ conceptuses
[24], we observed an expansion of the parietal trophoblast giant cell (P-TGC) layer in rescued
Ascl2lacZ/Del7AI placentae. The histology data also suggest a reduction in number or absence of
ASCL2 and glycogen trophoblast cells
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spongiotrophoblast and glycogen trophoblast (GlyT) cells in these mutants, the latter being
present in both the Jz and decidua at this developmental stage in wild-type placentae [24,43].
These abnormalities were not observed in the paternal +/Del7AI heterozygotes, which were
indistinguishable from wild-type placentae (Fig 4).
To describe this phenotype in more detail we conducted a marker analysis by in situ hybrid-
ization on E15.5 placentae of wild-type, +/Del7AI, and rescued Ascl2lacZ/Del7AI genotypes. First,
our results confirmed higher levels of Ascl2 expression in +/Del7AI compared to wild-type
spongiotrophoblast and further suggested a near-absence of Ascl2-expressing spongiotropho-
blast cells in rescued placentae (Fig 5). Both of these observations are supported by RT-qPCR
analyses (Fig 1D and S4B Fig). The near absence of a Jz was also confirmed by the severe
reduction in Tpbpa-positive cells in rescued placentae (Fig 5). In addition to strong expression
Fig 2. Phenotypic rescue of the mid-gestational lethality of Ascl2 mutants by paternal inheritance of Del7AI. (A)
Number of rescued embryos at E12.5 to E18.5 from crosses between Ascl2+/lacZ or Ascl2+/KO females and +/+ or
+/Del7AI males. ¶: includes 3 small and necrotic embryos. The data for individual litters are presented in S1 Table. (B)
Number of live Ascl2mutant pups at birth obtained from similar crosses. (C) Bar charts showing the percentage
observed over expected values from crosses analyzed in utero (left) and at birth (right). X-axis: male genotypes. Values
from crosses involving Ascl2+/lacZ and Ascl2+/KO females are shown in grey and black, respectively. The probability
values were obtained by the chi-square test of the null hypothesis of Del7AI = WT, where the rescue frequency of the
wild-type allele, 0.901%, is based on all crosses involving the Ascl2lacZ allele (3/333 Ascl2lacZ/+ progeny).  p<1×10−10.
https://doi.org/10.1371/journal.pgen.1007587.g002
ASCL2 and glycogen trophoblast cells
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Fig 3. Growth retardation of rescued Ascl2lacZ/Del7AI heterozygotes. (A) Scatterplots showing weights of rescued live
Ascl2lacZ/Del7AI pups (–/Del7AI, n = 7) and their wild-type littermates (n = 14) at postnatal days 0 (P0, birth), 7, and 21.
Scatterplots of E15.5 placental (B) and embryonic (C) weights of Ascl2lacZ/Del7AI conceptuses (–/Del7AI, n = 10) and
wild type littermates (n = 25). In all graphs, the bars show the average weight ± SD.
https://doi.org/10.1371/journal.pgen.1007587.g003
Fig 4. Hyperplastic parietal trophoblast giant cell layer in Ascl2lacZ/Del7AI placentae at E15.5. Heamatoxylin and
eosin (H&E, top) and DAPI (bottom) staining of wild-type, +/Del7AI and rescued Ascl2lacZ/Del7AI placental sections at
E15.5. DAPI staining readily identifies the large polyploid nuclei of the cells stacked at the giant cell layer in the
mutants. dec, decidua; P-TGC, parietal trophoblast giant cells; SpT, spongiotrophoblast cells; GlyT, glycogen
trophoblast cells; lab, labyrinthine layer. Dashed lines indicate the P-TGC layer boundary. Scale bar: 0.5 mm.
https://doi.org/10.1371/journal.pgen.1007587.g004
ASCL2 and glycogen trophoblast cells
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in SpT cells, Tpbpa is also expressed at lower levels in GlyT cells at this stage [30,31]. These
cells represent an important fraction of Tpbpa-positive cells in wild-type and +/Del7AI placen-
tae at E15.5, readily seen in the decidua, but are absent in rescued Ascl2lacZ/Del7AI conceptuses,
which only show a small layer of SpT cells. Loss of signal for Pcdh12 and Cdkn1c expression in
these compound heterozygotes provided further support for the absence of GlyT cells (Fig 5).
Pcdh12 is exclusively expressed in GlyT cells in the placenta [32] whereas Cdkn1c labels both
the labyrinth and GlyT cells at E15.5 [43,44]. Histological staining of glycogen content by
Fig 5. Abnormal spongiotrophoblast and glycogen trophoblast cell development in Ascl2lacZ/Del7AI placentae at
E15.5. Frozen sections of E15.5 placentae were analyzed for the expression of Ascl2, Tpbpa, Pcdh12, and Cdkn1c by in
situ hybridization. Periodic acid-Schiff (PAS) staining of glycogen was performed on paraffin sections of E15.5
placentae. Multiple sections from two placentae of each genotype, labeled at the top, were assessed and representative
pictures are shown. SpT, spongiotrophoblast cells; lab, labyrinthine layer; GlyT, glycogen trophoblast cells; P-TGC,
parietal trophoblast giant cells; dec, maternal decidua. Scale bars: 0.5 mm.
https://doi.org/10.1371/journal.pgen.1007587.g005
ASCL2 and glycogen trophoblast cells
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periodic acid-Schiff (PAS) showed that GlyT cells are absent in E15.5 Ascl2lacZ/Del7AI placentae
(Fig 5) as well as in the single E16.5 Ascl2KO/Del7AI rescued conceptus recovered (Fig 6A). At
this later stage, the mutant placenta also shows little sign of SpT cells and an extended labyrinth
layer reaching the hyperplastic P-TGC layer, with no sign of Jz. The presence of a dense and
disorganized labyrinth reaching the P-TGC layer was also evident in the expression patterns of
Prl3b1,Gcm1, and laminin (S5 Fig). Together our results show that as a consequence of
reduced Ascl2 levels the rescued mature placentae are severely hypoplastic for spongiotropho-
blast cells and lack GlyT cells.
ASCL2 is required for the emergence of glycogen trophoblast cells in the
ectoplacental cone
Although the histological detection of glycogen has long been used to identify mature GlyT
cells in the placenta past mid-gestation, few marker genes, such as Pcdh12 and Aldh1a3, have
been shown to label presumptive GlyT cell progenitors within the ectoplacental cone (EPC) at
E7.5-E8.5 [32,33]. Since Ascl2 is expressed at high levels in the EPC at those stages [3,42], we
studied the requirement for ASCL2 in the emergence of this progenitor population. Using
Fig 6. Absence of glycogen cell precursors in Ascl2 mutant placentae. (A) Histological sections of wild-type and
rescued Ascl2KO/Del7AI placentae at E16.5 were stained with heamatoxylin and eosin (H&E, top) or PAS with
heamatoxylin nuclear counter-stain (bottom). SpT, spongiotrophoblast cells; lab, labyrinthine layer; GlyT, glycogen
trophoblast cells; P-TGC, parietal trophoblast giant cells. Scale bar: 0.5 mm. (B) Immunofluorescence staining with
PCDH12 polyclonal antibodies (red) and phalloidin (green) on cryosections of E8.5 wild-type and Ascl2lacZ/+
conceptuses, counterstained with DAPI (blue). Scale bar: 0.1 mm.
https://doi.org/10.1371/journal.pgen.1007587.g006
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polyclonal anti-PCDH12 antibodies [45], the presumptive GlyT precursors are readily detected
in the EPC of wild-type conceptuses at E8.5 (Fig 6B). As previously reported, we found that
the EPC is already hypoplastic in Ascl2lacZ/+ mutants at this stage [3,42]. More importantly, the
few remaining EPC cells seen in Ascl2lacZ/+ mutants are not positive for PCDH12 (Fig 6B), sug-
gesting a failure to differentiate or maintain GlyT precursors in the absence of full Ascl2 levels.
Although PCDH12-positive cells were previously reported in the uterine crypt at E7.5 [32], we
found that such staining, visible notably in the Ascl2lacZ/+ mutants, represent a primary anti-
body-independent background (S6 Fig).
To analyze global gene expression profiles prior to a morphologically visible phenotype, we
mined RNA-seq datasets for wild-type and Ascl2lacZ/+ EPCs at E7.5 [46]. Overall, expression
levels for most of the 25,071 autosomal RefSeq genes queried are highly correlated between the
two genotypes (r = 0.9739, Fig 7A). We identified 217 significantly downregulated genes in the
mutant EPCs (Z-score< −1) and 72 upregulated genes (Z-score> 1, Fig 7A and S2 Table).
Ascl2 itself is expressed at only ~11% of wild-type levels from the Ascl2 hypomorphic allele in
the mutant EPCs. Other significantly downregulated genes include markers of GlyT precur-
sors in the EPC such as Pcdh12 [32], Aldh1a3 [33], and Tpbpa [31], as well as placental prolac-
tin-related genes expressed in both E8.5 EPC and E14.5 GlyT cells, such as Prl6a1, and Prl7c1
(Figs 7B and 7C, and S3 Table) [47]. Other genes significantly downregulated in the Ascl2
mutant EPC and expressed in GlyT cells of the mature placenta include Car2, Plau, Ncam1,
and Prdm1/Blimp1 (Fig 7A) [48–50]. The RNA-seq data show that relatively few genes are
affected at this early stage by the loss of more than 90% of Ascl2 mRNA in the E7.5 EPC, but
also that, significantly, several of the affected genes are known markers of the GlyT cell lineage.
Markers of GlyT cell precursors are not induced upon differentiation of
mutant Ascl2lacZ/+ TSCs
The observation that Ascl2lacZ/+ EPCs lack PCDH12-positive cells in vivo and show broad
defects in the expression of several GlyT cell markers suggest that ASCL2 might be required as
early as E7.5 for the differentiation of this trophoblast lineage. To look at these early events, we
established TSC lines from Ascl2+/+ and Ascl2lacZ/+ littermate blastocysts. Cell lines of both geno-
types were recovered, with no visible differences in morphology or growth when maintained
under undifferentiated growth conditions. Ascl2 is expressed at ~14% of wild-type levels on
average in the mutant TSC lines (Fig 8A), similar to the results obtained in EPCs (Fig 7B). This
suggests that Ascl2 is not required for the derivation or self-renewal of undifferentiated TSCs,
consistent with the absence of morphological defects prior to E8.5 in Ascl2-null conceptuses [3].
Wild-type and mutant TSC lines were differentiated by FGF4 and fibroblast conditioned
medium withdrawal for 8 days and lineage markers were analyzed by RT-qPCR. Within 24
hours of differentiation, lines of both genotypes showed a drastic decrease in the levels of Cdx2
mRNA, a marker of undifferentiated TSCs (Fig 8A) [18]. Whereas Pcdh12 [32], Tpbpa [30], and
Car2 [48] are induced within ~4 days of differentiation of wild-type TSCs, the mutant cells
failed to activate these markers of GlyT (Pcdh12) and Jz cells (Tpbpa, Car2; Fig 8A). Although
levels of the P-TGC marker Prl3d1 [47] were reduced ~8-fold in the differentiated mutant
TSCs, endoreduplication was not affected (Fig 8B and S7 Fig). The results show that Ascl2 is
required for the differentiation of GlyT precursors from undifferentiated TSCs, revealing a
novel function for this bHLH transcription factor in early trophoblast development.
Discussion
Glycogen trophoblast cells represent an abundant lineage of the mature mouse placenta
although both the origin and function of these cells remain unknown. Originally characterized
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Fig 7. RNA-seq analysis of wild-type and Ascl2-deficient E7.5 ectoplacental cones. (A) Scatter plot showing average
RPKM values for 25,071 autosomal RefSeq genes, from the RNA-seq analysis of dissected E7.5 EPCs from three wild-
type (Ascl2+/+) and three mutant (Ascl2lacZ/+) littermates. Significantly upregulated genes (72 genes, Z> 1) and
downregulated genes (217 genes, Z< −1) are shown in blue and red, respectively. r: Pearson correlation coefficient. (B)
Average RPKM values for selected genes known to be expressed in spongiotrophoblast and glycogen trophoblast
derivatives of EPC progenitors, from the RNA-seq analysis of E7.5 EPCs of given genotypes. Ppia is included as a
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by their accumulation of large cytoplasmic stores of glycogen past mid-gestation, they were
first detected as cell clusters within the Jz from ~E12.5 [29]. GlyT cells are migratory and start-
ing at ~E14.5 they cross the P-TGC layer and invade the decidua, a property they share with
SpA-TGCs [26,29]. Between E12.5 and E16.5 they are highly proliferative and expand more
than 250-fold, while SpT cells increase by less than 4-fold [43]. More than 50% of these cells
lose their glycogen content after E15.5. Consequently, it was proposed that GlyT cells might
provide energy for embryonic growth late in gestation or for triggering parturition [29,43,51].
A number of observations suggest that GlyT precursor cells are already specified in the
EPC. The most compelling evidence comes from the expression patterns of markers specific to
GlyT cells in mature placentae and also expressed in specific cells of the EPC at E7.5 to 8.5,
such as Pcdh12 and Aldh1a3 [32,33]. Several other markers are expressed in the EPC and later
in GlyT cells of the mature placenta, but unlike Pchd12 and Aldh1a3, these are also expressed
in other trophoblast cell types. Cre/loxP-based cell lineage tracing experiments have been per-
formed for two of those genes, Tpbpa and Prdm1, and confirmed their expression in GlyT
amongst other trophoblast cell types in mature placentae [26,49]. However, Cre recombination
and activation of the conditional reporters used were not documented in EPC, therefore leav-
ing the possibility that GlyT cells were labelled only past mid-gestation, within the Jz. Another
line of evidence comes from the direct detection of few glycogen-containing cells within the
middle top portion of the EPC at E6.5–7.5 using histological PAS staining [32,52]. Together,
these results suggest that the EPC contains different diploid populations, including precursors
of GlyT cells initially found in the proximal portion of the EPC.
Here we show that the bHLH transcription factor ASCL2, which is broadly expressed in the
EPC, is required for the presence of these GlyT cell precursors. Since heterodimerization with
one of the E proteins is required for ASCL2 function [8], the subset of EPC cells developing as
GlyT cell precursors may therefore be at least in part dictated by restricted expression of E pro-
tein genes. Both Tcf4 and Tcf12, coding for the E proteins E2-2/ITF2 and HEB/ALF1, but not
Tcf3, are expressed in the EPC at E8.5. However the available data suggest that both are mostly
expressed in the distal portion of the EPC, closer to the chorion [8]. In contrast to those results,
the RNA-seq data on individual wild-type EPC at E7.5 show that those three genes, including
Tcf3, are expressed at this stage, with the following RPKM values: Tcf3, 6.74±0.31; Tcf4, 9.80
±0.22; and Tcf12, 15.68±1.25 [46]. Mice deficient for any of these three E protein genes die
before weaning, with no report of abnormalities suggesting a developmental phenotype, except
perhaps for the Tcf4-/- mice, which are recovered at low frequency at birth [53–55]. Whether
the development of GlyT precursors is affected in any of those mutants, with the possibility of
redundancy, still needs to be addressed.
Mature placentae developing from EPCs expressing Ascl2 at suboptimal levels show a severe
reduction in SpT cells and an absence of GlyT cells, as seen in Del7AI/+ placentae (~60% of
wild-type Ascl2 levels) [24] and in the current description of Ascl2lacZ/Del7AI rescued placentae
(~41% of wild-type levels). Our observations that several GlyT cell markers are downregulated
in mutant EPCs before the manifestation of a visible phenotype and that Ascl2-deficient TSCs
fail to upregulate Pcdh12 and Tpbpa upon differentiation both support the conclusion that
ASCL2 is required in diploid EPC cells for the emergence or early maintenance of the GlyT
cell lineage. Together with previous observations [3,24,42] our results show that Ascl2 function
is level-sensitive in the trophoblast. Total Ascl2 mRNA expression levels between ~60% and
~40% of wild-type levels are compatible with development to term but are associated with a
housekeeping gene control.  p<0.05;  p<0.01;  p<0.005. (C) Fold change in RPKM values (mutant/wild-type) for
the genes analyzed in B. Graphs show average and SD for three biological replicates per genotype.
https://doi.org/10.1371/journal.pgen.1007587.g007
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Fig 8. Differentiation defects of Ascl2lacZ/+ trophoblast stem cells. (A) Wild-type (Ascl2+/+) and mutant (Ascl2lacZ/+)
TSCs were differentiated by FGF4 and conditioned medium withdrawal for 8 days and RNA samples were collected at
the time points shown. Expression levels for Ascl2,Cdx2, Pcdh12, Tpbpa, Car2, and Prl3d1were analyzed by RT-qPCR
and expressed as levels relative to those of the house-keeping gene Ppia. The graphs show the average ± SD for technical
triplicates. (B) Flow cytometric analysis of ploidy during TSC differentiation, performed by DNA staining with
propidium iodide. Cells of higher ploidy (8n and 16n) are seen in differentiated cells of both genotypes starting at day 6
of differentiation. FACS profiles are shown in S7 Fig.
https://doi.org/10.1371/journal.pgen.1007587.g008
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severe placental phenotype leading to embryonic growth retardation. Although GlyT cells are
deficient in these models and could contribute to the observed embryonic growth phenotype,
we also described several other associated placental abnormalities which could contribute to
an insufficient placenta. Specific ablation of the GlyT cell lineage using a conditional approach
previously applied to other trophoblast lineages would be required to establish the develop-
mental function of this cell population [56,57].
As Ascl2 mRNA levels fall below ~60% of wild-type levels, the placenta fails to develop nor-
mally although it can still support the development of most growth restricted embryos to term
(S8 Fig). Although the placentae of Ascl2lacZ/Del7AI and Del7AI/+ mutants shares similarities
[24], the phenotype described here for Ascl2lacZ/Del7AI mutants is more pronounced, with
fewer persisting SpT cells, consistent with the lower overall Ascl2 levels. The postnatal survival
rate of Ascl2lacZ/Del7AI mutant pups is consequently much lower (22% vs. 100%), although the
cause of the late lethality is currently unknown [28]. At the molecular level, there are two addi-
tional distinctions between these two models; i) the maternally expressed form of placental
tyrosine hydroxylase, Th [36,58], is deleted in Del7AI/+ but not in Ascl2lacZ/Del7AI mutants; ii)
whereas Phlda2 is upregulated in the Del7AI/+ model [24], we found that Phlda2 mRNA levels
are similar in wild-type and rescued Ascl2lacZ/Del7AI placentae at E13.5 (S4B Fig). The RNA-
seq analysis of E7.5 EPCs also failed to detect a significant increase in Phlda2 levels in the
Ascl2lacZ/+ mutants, with RPKM values of 107.0±7.0 and 115.2±6.9 in the wild-types and
mutants, respectively (Z-score = 0.551; Fig 7B and 7C). Phlda2, like Ascl2, is also maternally
expressed and regulated by Kcnq1ot1 [10,59]. Although overexpression of Phlda2 (2.3- to
4-fold) from BAC transgenes causes a reduction in the volume of the junctional zone, as seen
in Ascl2 hypomorphs, the phenotype described here is much more pronounced and is also
associated with an expansion of the P-TGC layer, not seen with increased Phlda2 levels [60].
A recent study also described the consequences of overexpressing Ascl2 by ~6-fold in the
trophoblast via BAC transgenesis [61]. Although the authors reported a decrease in the average
Jz volume at E14.5, when Ascl2 levels are normally lower, the spongiotrophoblast and GlyT cell
populations were not affected at earlier stages (E10.5–12.5). Importantly, the transgene leads
to higher levels of Ascl2 in the labyrinth, where it is normally expressed at low levels in a few
scattered cells, and this overexpression is accompanied by ectopic clusters of PAS-positive,
Tpbpa-positive cells within the labyrinth [61]. We propose that some of the expressing labyrin-
thine cells are able to acquire a GlyT cell phenotype at this ectopic location due to higher Ascl2
levels. Those results thus provide additional evidence that Ascl2 plays a critical role in the
emergence of GlyT cells within the trophoblast. It would be important to precisely define the
nature of the cell types expressing Ascl2 in wild-type labyrinth and study its function in this
cell population using a conditional mutagenesis approach [4].
Another important aspect of our work is the mechanism by which Del7AI leads to partial
LOI at Ascl2. Through our analyses in vivo and in mutant TSCs, we estimated that the paternal
Del7AI allele allows an abnormal expression of Ascl2 representing ~30% of the wild-type
mRNA levels transcribed from the maternal allele. This could imply that all +/Del7AI ASCL2-
positive cells express the paternal Ascl2 allele at low levels (constitutive partial LOI) or that
only ~30% of those cells experience full LOI and express Ascl2 biallelically (mosaic full LOI).
Our observations that +/Del7AI placentae show broad overexpression of Ascl2 in SpT cells and
that much fewer than 30% of Tpbpa-positive SpT cells persist in Ascl2lacZ/Del7AI rescued pla-
centae (Fig 5) strongly support the former scenario. More importantly, unlike what is observed
for the Ascl2lacZ allele, the paternal Del7AI allele essentially fails to rescue the KO allele (Fig 2).
If the observed Ascl2lacZ/Del7AI rescue was attributable to 30% of the cells expressing Ascl2 at
wild-type levels from the paternal Del7AI allele (mosaic full LOI), we would expect similar res-
cue frequencies and phenotypes in both Ascl2lacZ/Del7AI and Ascl2KO/Del7AI conceptuses. Since
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our deletion can only rescue the Ascl2lacZ allele, our results are consistent with the frequency of
rescue being dependent on the overall levels of Ascl2 mRNA per cell, with the paternal Del7AI
allele allowing Ascl2 expression at ~30% of wild-type levels by constitutive partial LOI.
Silencing of the paternal allele of Ascl2 is dependent on expression of the lncRNA Kcnq1ot1
in cis, which is itself silenced on the maternal allele by a DNA methylation mark directly inher-
ited from oocytes [10,13,62–64]. A conditional deletion of the Kcnq1ot1 promoter showed that
continuous expression of the lncRNA is required to maintain silencing of the paternal Ascl2
allele in vivo [65]. The mechanism by which Kcnq1ot1 silences Ascl2 and other maternally
expressed genes in the region is mediated in part by recruitment of histone modifying enzymes
such as EHMT2/G9A, EZH2 (PRC2 component), and RNF2 (PRC1 component), and cis
deposition of the repressive histone marks H3K9me2, H3K27me3, and H2AK119ub1 on the
paternal allele of the repressed genes [11,14,15,66]. The most parsimonious explanation for the
observed LOI at Ascl2 is that the Pgk-loxP-neo-pA cassette present at the deletion junction, 4.3
kb downstream of Ascl2, interferes with some aspect of Ascl2 silencing [28]. However, we have
not detected any paternal Ascl2 expression from the Pgk-loxP-neo-pA-loxP insertion allele
(Ascl2M2) used to define the deletion breakpoint [28] when we analyzed Ascl2CAST/M2 placental
RNA (S1A–S1C Fig). Furthermore, the Ascl2M2 allele could not rescue the embryonic lethality
of the maternal Ascl2lacZ mutation above the rate of reversion seen with a wild-type paternal
allele (S1.3 Table).
Another possibility is that the Del7AI deletion removes sequences required for spreading or
stable maintenance of the Kcnq1ot1 silencing domain all the way to Ascl2. A number of obser-
vations lend support to this hypothesis. First, RT-PCR evidence supported by RNA knock-
down and promoter deletion suggests that the lncRNA Kcnq1ot1 can extend up to 470 kb from
its promoter, past Ascl2 and Th (S2A and S9A Figs) [36]. Here, we have shown that the longer
isoform of Kcnq1ot1, up to 307 kb, appears normally produced from the paternal Del7AI allele,
but obviously a large fraction of this isoform is missing because of the deletion (S9 Fig). Sec-
ond, we and others showed that the Th gene, located in between Ascl2 and Ins2, is expressed at
low levels and only from the maternal allele in placenta and TSCs [36,58,67]. We found that
placental Th is produced as a maternally-expressed chimeric transcript, initiating within an
endogenous retroviral LTR element (RMER19A) located in between Ascl2 and Th, and at least
partially silenced via a Kcnq1ot1-dependent mechanism on the paternal allele [58]. Third, we
have previously shown that a ubiquitous EGFP transgene inserted upstream of Ins2, at the site
defining the proximal breakpoint of Del7AI, is maternally expressed in a Kcnq1ot1-dependent
mechanism (S9B Fig) [58]. Fourth, an 800-kb YAC transgene of the Kcnq1ot1 imprinted
domain, extending from Nap1l4 to past Th [68], can recapitulate appropriate imprinted
expression of most genes present on the transgene when integrated at an ectopic genomic loca-
tion [69]. Strikingly, unlike the other protein-coding imprinted genes on the construct, both
Ascl2 and Tssc4 failed to be silenced upon paternal transmission of this YAC transgene. Since
silencing of the same two genes is perturbed by Del7AI, and based on the observations
described above, we propose that sequences in between Th and Ins2 are required to establish a
full functional silencing domain dependent on Kcnq1ot1 transcription (S9D Fig). Further
experimental support for such an extended domain of Kcnq1ot1 silencing would require the
analysis of Kcnq1ot1-dependent deposition of repressive histone marks in the region or the
description of intra-chromosomal interactions between Kcnq1ot1 lncRNA and sequences
around the Th locus, as described for Kcnq1 [66], and could lead to further understanding of
the mechanism of silencing and spreading in this imprinted domain. Alternatively, 3’ end
sequences missing from the longer Kcnq1ot1 isoform expressed from Del7AI–and possibly
from the YAC transgene as well–could be critical for establishment of a fully silenced domain
on the paternal allele. Kcnq1ot1 truncation alleles could potentially be exploited to delimit
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those putative critical elements of the lncRNA, although the available evidence suggests that
transcription of this lncRNA can somehow bypass the termination signals of at least three
genes: Trpm5, Ascl2, and Th (S9 Fig).
Materials and methods
Ethics statement
Mice were bred and maintained in the Centre for Disease Modelling, Life Sciences Institute,
University of British Columbia, under pathogen-free conditions. All animal experiments were
performed under certificates A07-0160, A11-0293, and A15-0181 from the UBC Animal Care
Committee and complied with the national Canadian Council on Animal Care guidelines for
the ethical care and use of experimental animals.
Mice and genotyping
For all heterozygous genotypes, the maternal allele is always presented first. For simplicity,
Ascl2–/+ +/Del7AI compound heterozygotes are referred to as Ascl2–/Del7AI. The generation and
genotyping of the Del7AI (Del(7Ascl2-Ins2)1Lef; MGI ID:3662901) and M2 (Ascl2tm2Nagy; MGI ID:
4399141) alleles were previously described [28]. The Del7AI deletion spans a ~280 kb region,
from a SpeI site 2.7 kb upstream of Ins2 exon 1 to a NcoI site 4.3 kb downstream of Ascl2 exon
3 (positions 142,682,271–142,962,499 on GRCm38/mm10) and deletes a single known protein-
coding gene, Th. The junction contains a Pgk-loxP-neo-pA cassette transcribed on the (-) strand,
like Ascl2 and Ins2 [28]. Two different Ascl2 (Mash2) mutant alleles were used in this study. The
original Ascl2KO allele [3] deletes most of the Ascl2 open reading frame and is therefore a null
allele (Ascl2tm1Alj; MGI ID: 2153832). In the lacZ knock-in allele Ascl2lacZ (Ascl2tm1.1Nagy; MGI
ID:2155757) an IRES-lacZ-pA reporter inserted in the 3‘UTR of Ascl2 destabilizes the bicistro-
nic mRNA leading to embryonic lethality at E10.5, as seen in Ascl2KO/+ heterozygotes [42]. The
animals in this study were all on the CD-1 outbred mouse background except for allele-specific
studies, in which one parent is an incipient congenic for a Mus mus. castaneus (CAST/EiJ) distal
chromosome 7 haplotype on a mixed CAST/EiJ × C57BL/6J background. Since they were origi-
nally derived from R1 ES cells [70], the mutant alleles are all on strain 129S1 or 129X1 Chr7
haplotypes. Weights of placentae and embryos were taken immediately upon dissection with as
much of the liquid removed as possible before weighing.
Allele-specific expression analysis and quantitative reverse transcriptase
(RT-qPCR)
For allele-specific expression analyses of IC1- and IC2-regulated genes, random-primed
cDNA was generated from E9.5 or E13.5 placental RNA as described previously [24]. For
Ascl2, the SNP analyzed is a C to T transition within a HpaII site in the 3’ UTR (position 1471
of RefSeq mRNA NM_008554.3). RT-PCR with primers 1148F and 726R yielded a 725-bp
fragment which upon HpaII digestion gives a CAST-specific 316-bp band and 129-specific
218- and 98-bp bands, in addition to common bands of 99 and 310 bp (S1 Fig). For Tssc4,
RT-PCR with primers F1 and R35 followed by HaeIII digest give a CAST-specific 247-bp band
and a 129-specific 159-bp band. For Cdkn1c, primers p57S and p574 give a 364-bp product
and the CAST>129 SNP is C>T at position 316. For Phlda2, primers Ipl 1 and Ipl R2 yield a
578-bp product and the CAST>129 SNP is A>C at position 209. For Cdkn1c and Phlda2,
direct sequencing of the PCR products followed by Phred analysis [71] was performed to
determine allelic expression ratios. For total expression level determination, cDNAs were ana-
lyzed by RT-qPCR. Total RNA was purified using Trizol (Invitrogen) according to
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manufacturer’s directions and DNase-treated (RQ1, Promega) for at least 1 h to remove con-
taminating gDNA. RNA was reverse-transcribed with SSII (Invitrogen), using random prim-
ers (N15) according to the SSII protocol. Quantitative PCR was performed on a Step-One Plus
Real time PCR system (Applied Biosystems) using Eva Green (Biotium). Ct values of three bio-
logical replicates, obtained by the LinReg PCR program [72], were averaged and used to calcu-
late relative amounts of transcripts, normalized to levels of the housekeeping gene Ppia [73].
All primer sequences are available in S4 Table.
In situ hybridization (ISH) and immunohistochemistry (IHC)
E13.5 and E15.5 placentae were dissected in PBS and fixed in fresh 4% paraformaldehyde/
1×PBS (RNase-free) overnight at 4˚C. For E9.5 placentae, entire conceptuses were fixed to
ensure integrity of cryostat sections during the ISH procedure. Antisense and sense strand
probes for Ascl2, Tpbpa/4311, Pcdh12, Cdkn1c, and Igf2were DIG-labeled and used for ISH on
10-μm cryostat sections from E13.5 and E15.5 placentae as previously described [25]. Nuclear
fast red was used as the counterstain. The Igf2 probe sequence was obtained from www.
genepaint.org (Accession number NM_010514; probe 486) and amplified from E13.5 placenta
cDNA. IHC for laminin was done as previously described [24]. Slides were treated to remove
paraffin, hydrated, and blocked with 0.3% hydrogen peroxide for 30 minutes and then with
5% goat normal serum, 0.5% BSA in PBS-T. Slides were incubated with rabbit polyclonal anti-
laminin (Sigma L9393, at a 1/50 dilution in serum blocking solution) overnight at 4˚C. The
next day, the secondary biotinylated goat anti-rabbit antibody (Jackson ImmunoResearch)
was added at a dilution of 1/500 and incubated for 30 minutes. ABC (Vector) was added for 30
minutes and DAB for 1 minute. Sections were counterstained with hematoxylin and washed in
Scott’s Tap water solution (2% MgSO4, 0.35% NaHCO3 in distilled water) to help sharpen the
contrast. Sections were then dehydrated and mounted with Entellan mounting medium (EM
Science) under glass coverslips.
Periodic acid-Schiff (PAS) staining
Placental paraffin sections were treated to remove paraffin, hydrated, and oxidized in 0.5%
periodic acid solution for 5 minutes. Slides were placed in Schiff Reagent for 15 minutes, coun-
terstained with hematoxylin, and washed in Scott’s tap water solution to help sharpen the con-
trast. Sections were then dehydrated and mounted with Entellan mounting medium (EM
Science) under glass coverslips. Consecutive sections of one placenta per genotype were
examined.
Immunofluorescence
For PCDH12 localization analyses, entire E8.5 conceptuses were processed for cryostat frozen
sections as described [74]. The affinity-purified anti-PCDH12 polyclonal antibodies were pre-
pared and used as described [45]. For F-actin staining, sections were washed with water, coun-
terstained with phalloidin (1/400, Invitrogen) for 20 minutes at room temperature, washed
again with water, and counterstained with 4’,6-diamindino-2-phenylindole (DAPI, 2 μg/ml,
Sigma) for 5 minutes at room temperature. At early developmental stages, we found that stain-
ing for F-actin was much stronger in maternal cells, allowing a clear demarcation of the con-
ceptus-uterus boundary. Sections were washed with water and mounted on glass slides under
coverslips with Vectashield (Vector Labs). The samples were analyzed on a Leica DMI6000B
inverted fluorescent microscope and images were captured and processed with a Q-imaging
Retiga 4000R monochrome camera and Openlab (Improvision).
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Analysis of RNA-seq data
The NGS datasets for the EPC RNA-seq analysis [46] were downloaded from GEO (accessions
GSM1613552-7) and aligned to the mouse genome (mm9) using STAR two-pass mapping for
de novo splice-junction generation with default parameters [75]. Data were input into Seq-
Monk (http://www.bioinformatics.babraham.ac.uk/projects/seqmonk/) for further analysis,
removing reads with a mapping quality score of less than 5. RPKM values were generated
using SeqMonk’s RNA-Seq Quantitation Pipeline, normalizing read count by gene length.
Trophoblast stem cells
All the TSC lines used in this study were established from E4.0 blastocysts, expanded, and
maintained as described [18]. TSCs were grown in RPMI 1640 (Invitrogen) supplemented
with 50 μg/ml penicillin/streptomycin, 20% fetal bovine serum (Wisent), 1 mM sodium pyru-
vate, 100 μM β-mercaptoethanol, 2 mM L-glutamine, 70% 3-day feeder-conditioned medium,
25 ng/ml human recombinant FGF4 (Sigma F2278) and 1 μg/ml heparin (Sigma H3149).
Cells were collected for genotyping and sexing by PCR; only XY male cells were selected for
expression studies. Differentiation of TSCs was induced by omission of FGF4 and fibroblast-
conditioned medium in the culture. The flow cytometric analysis of ploidy during TSC differ-
entiation was performed by DNA staining with propidium iodide as described [76]. All data
were obtained on a BD LSRII running BD FACS DIVA and analyzed in FlowJo 9.5.
Statistical analysis
For RT-qPCR, weight comparisons, and RNA-seq expression data, statistical significance was
determined using the Student’s t-test (unpaired, two tailed distribution), and data were pre-
sented as mean ± SD. For the rescue experiments, the probability values were calculated using
the chi-square test of statistical significance against the null hypothesis of Del7AI(or M2) = WT
allele in its ability to rescue the embryonic lethality of maternal Ascl2 mutations. The rescue
frequency of the wild-type allele, 0.901%, is based on all crosses involving the Ascl2lacZ allele (3/
333 Ascl2lacZ/+ progeny) and was used to calculate the expected numbers of Ascl2–/Del7AI or
Ascl2–/M2 progeny (S1.3 Table).
Supporting information
S1 Fig. Allele-specific expression of Ascl2 in wild-type and +/Del7AI placentae. (A) Diagram
of the Ascl2 725-bp exons 2–3 RT-PCR product (primers 1 + 4) showing the positions of HpaII
sites for the 129 and CAST (C) alleles with sizes of each fragment given in base pairs. The poly-
morphic HpaII site within the 3’ UTR is marked by an asterisk. (B) Non-radioactive blot of the
HpaII-digested RT-PCR products, hybridized with a DIG-labelled probe from the 218-bp 129
HpaII band (shown in A). The RNA samples analysed are from E9.5 placentae of the given
genotypes, where C is the maternal CAST allele and M2, the targeted PGK-loxP-neopA-loxP
insertion (Ascl2tm2Nagy) used to define the distal breakpoint of the Del7AI deletion. M, maternal;
P, paternal. (C) Allelic ratios (maternal/paternal) for each sample, as determined by ImageJ
analysis of the data presented in B. (D) Diagram of the Ascl2 genome from exon 2 to 3, showing
the positions of PCR primers for genomic (E) and RT-PCR (F) analyses. The asterisk marks the
position of the polymorphic HpaII site. The reverse primer 3 (129R) is 129-specific at its 3’ ter-
minal nucleotide. (E) Intron 2 to exon 3 PCR on genomic DNA from pure 129 and CAST mice
as well as a CAST/Del7AI embryo (C/Δ). Lanes–and M are water controls and a 100-bp marker.
(F) Exon 2 to exon 3, 129-specific RT-PCR on cDNA from wild type (C/+) and mutant (C/Δ)
placentae. Lanes–, + and M are water control, a 129 Ascl2 cDNA clone, and a 100-bp marker,
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respectively. PCR primers: 1, 1148F; 2, in2F1; 3, 129R (129-specific); 4, 726R. PCR primers used
are shown at the bottom of each gel figure. Their sequences are given in S4 Table.
(PDF)
S2 Fig. Expression of Kcnq1ot1 in +/Del7AI placentae. (A) UCSC Genome Browser screen-
shot for the Kcnq1ot1 imprinted domain. From the top, the tracks show: (i) The positions of
PCR reactions used by Golding (2011) to define the longest Kcnq1ot1 isoform. (ii) The three
PCR reactions used in this study. (iii) The extent of the Del7AI deletion. (iv) The longer Kcnq1ot1
isoforms reported by Golding (2011, ~470 kb)) and Redrup (2009, ~121 kb), as well as the more
stable and annotated transcript of ~83 kb. All are transcribed on the (-) strand, from a transcrip-
tional start site (TSS) within intron 11 of Kcnq1. Note that ~130 kilobases of the longest isoform
are deleted in Del7AI. (v) UCSC genes annotated in the region, including Ascl2, located immedi-
ately distal of the Del7AI breakpoint. (B) RT-PCR detection of Kcnq1ot1 at 0.3, 202, and 307 kb
downstream of the TSS, on E13.5 placental RNA from two +/Del7AI and one wild-type control
conceptuses. PCRs were performed on total RNA samples, with (+) or without (-) reverse tran-
scriptase (RT) priming of cDNA with random primers (N15). C-: water control. C+: genomic
DNA. The molecular weight ladder is the exACTGene 100bp ladder (Fisher Scientific).
(PDF)
S3 Fig. Paternal Igf2 expression is unaffected in +/Del7AI placentae at E13.5. (A) Igf2RT-
qPCR on wild type and +/Del7AI E13.5 placental cDNA. Expression is relative to Ppia. Three
biological replicates for each genotype were analysed. Graphs show mean ± SD.
(B) Igf2 ISH on frozen sections of wild type and +/Del7AI E13.5 placentae. Multiple sections
from two placentae of each genotype were assessed and representative pictures are shown. The
sense probe gave no signal (not shown). The blue stain shows Igf2 expression, mostly in the
junctional zone and GlyT cells in the decidua. Scale bar: 0.5 mm. jz, junctional zone; lab: laby-
rinth; dec, decidua.
(PDF)
S4 Fig. Effect of Del7AI on Ascl2 mRNA levels in differentiated TSCs and rescued placentae.
(A) Trophoblast stem cell (TSC) lines of the given genotypes were differentiated for 2 days by
FGF4 withdrawal and Ascl2 levels, normalized to Ppia levels, were measured by RT-qPCR. In
paternal deletion mutants (+/Del7AI), total Ascl2 levels are increased by 1.6-fold over wild-type
TSCs (, p<0.05). Graphs show mean + SD. The numbers of independent TSC lines of each
genotype analysed (biological replicates) are given at the bottom (n =). (B) Relative levels of
Ascl2 and Phlda2 in E13.5 wild-type and Ascl2lacZ/Del7AI rescued placentae, determined as
described in A. Three samples of each genotype were analysed and graphs show mean ± SD of
biological triplicates (, p = 0.0003).
(PDF)
S5 Fig. Abnormal labyrinth development in Ascl2lacZ/Del7AI placentae at E15.5. Frozen sec-
tions of E15.5 placentae of the given genotypes were analysed for the expression of Prl3b1 and
Gcm1 by ISH. The basement membrane marker laminin was detected by IHC on paraffin sec-
tions. Scale bar: 0.5 mm. Spt, spongiotrophoblast cells; dec, decidua; P-TGC, parietal tropho-
blast giant cells; lab, labyrinthine layer.
(PDF)
S6 Fig. Primary antibody-independent staining in the decidua. Adjacent sections of the
Ascl2lacZ/+ E8.5 conceptuses analysed in Fig 6B were treated as described in this figure but
without incubation with the anti-PCDH12 primary antibodies. Punctate staining for the sec-
ondary antibody (arrow) is still visible above the giant cell layer, within the decidua. P-TGC,
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parietal trophoblast giant cells; dec, decidua; ch, chorion.
(PDF)
S7 Fig. Endoreduplication of differentiating wild-type and Ascl2lacZ/+ TSCs. (A) Cell-cycle
distribution of wild-type and Ascl2lacZ/+ mutant TSCs as monitored by flow cytometry using
propidium iodide staining. Profiles were generated on the indicated days following FGF4 and
conditioned medium withdrawal. 2n marks diploid cells in G1 phase, whereas 4n represents a
mixture of G2-phase diploid and G1-phase tetraploid cells. Endoreduplication is clearly seen
at higher ploidies. (B) Images of wild-type and Ascl2lacZ/+ mutant TSCs at d0 and d4 of differ-
entiation. Scale bar, 100 μm. Refers to data presented in Fig 8B.
(PDF)
S8 Fig. Dosage-sensitive effects of Ascl2 mRNA levels on placental phenotype. For each
genotype, the approximate total Ascl2 mRNA levels are presented as a percentage of the wild-
type levels, set at 100%.
(PDF)
S9 Fig. Potential critical region for extended Kcnq1ot1 silencing. (A) Structure of the
IC1-IC2 imprinted domains on distal mouse Chr7, drawn to scale. Paternally expressed genes
are in blue, maternally expressed genes in red. Two isoforms of Kcnq1ot1 have been described;
the more stable form terminates within intron 10 of Kcnq1, whereas a longer form has been
detected, extending all the way past Th, a gene maternally expressed in placenta from the LTR
RMER19A (Jones, 2011). (B) The Tel7KI allele carrying a pCAGGS-EGFP reporter inserted
upstream of Ins2. The EGFP is imprinted and maternally expressed in the embryo in a
Kcnq1ot1-dependent manner (Jones, 2011). (C) Del7AI allele, showing partial LOI at Ascl2 and
Tssc4 upon paternal transmission. (D) YAC transgene showing appropriate imprinting of the
IC2 domain, except at Ascl2 and Tssc4 (Cerrato, 2005). In both C and D, the 3’ end structure of
the longer Kcnq1ot1 isoform is unknown (question marks).
(PDF)
S1 Table. S1.1 Table. Litters collected to assess the rescue of the Ascl2lacZ mutation in utero.
S1.2 Table. Litters collected to assess the rescue of the Ascl2KO mutation in utero.
S1.3 Table. Chi-square tests of rescue data.
(XLSX)
S2 Table. S2.1 Table. Significantly down-regulated autosomal genes (Z-score < -1) identified
by RNA-seq analysis of wild-type and Ascl2lacZ/+ mutant EPC at E7.5.
S2.2 Table. Significantly up-regulated autosomal genes (Z-score> 1) identified by RNA-seq
analysis of wild-type and Ascl2lacZ/+ mutant EPC at E7.5.
(XLSX)
S3 Table. RPKM values for all expressed Prl genes, from RNA-seq analysis of wild-type and
Ascl2lacZ/+ mutant EPC at E7.5, as well as their reported expression pattern in the placenta.
(XLSX)
S4 Table. Primers used in this study.
(PDF)
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